Sorrento Therapeutics (SRNE)

Sorrento Therapeutics (SRNE) Financial Statements


Sorrento Therapeutics Financial Overview

Sorrento Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.056; its P/E ratio is >-0.01; Sorrento Therapeutics is scheduled to report earnings on August 10, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 12.61M$ 10.60M$ 15.59M$ 17.40M$ 11.46M
Gross Profit$ 15.03M$ -8.99M$ -5.42M$ 9.13M$ 5.76M
EBIT$ -105.20M$ -141.66M$ -210.98M$ -90.91M$ -218.28M
EBITDA$ -99.48M$ -136.73M$ -209.85M$ -87.55M$ -215.05M
Net Income Common Stockholders$ -95.21M$ -139.62M$ -223.69M$ -89.58M$ -218.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.64M$ 50.32M$ 49.98M$ 117.86M$ 133.60M
Total Assets$ 456.77M$ 460.06M$ 472.84M$ 615.61M$ 632.13M
Total Debt$ 207.60M$ 169.55M$ 134.50M$ 168.21M$ 204.61M
Net Debt$ 126.97M$ 119.23M$ 84.53M$ 50.35M$ 71.00M
Total Liabilities$ 654.65M$ 587.48M$ 494.51M$ 485.41M$ 496.37M
Stockholders Equity$ -205.11M$ -125.50M$ -18.61M$ 131.85M$ 132.02M
Cash Flow-
Free Cash Flow$ -55.80M$ -49.55M$ -72.86M$ -65.01M$ -83.69M
Operating Cash Flow$ -55.66M$ -49.46M$ -68.34M$ -61.17M$ -80.99M
Investing Cash Flow$ -140.00K$ 1.68M$ -5.03M$ -8.09M$ -1.73M
Financing Cash Flow$ 88.81M$ 61.20M$ 25.08M$ 71.50M$ 41.77M
Currency in USD

Sorrento Therapeutics Earnings and Revenue History

Sorrento Therapeutics Debt to Assets

Sorrento Therapeutics Cash Flow

Sorrento Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis